FindTrial
Sign In

Evaluation of clinical efficacy of comprehensive Chinese and Western medicine in the treatment of acute respiratory distress syndrome

Evaluation of clinical efficacy of comprehensive Chinese and Western medicine in the treatment of acute respiratory distress syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002296
Enrollment
Unknown
Registered
2019-04-22
Start date
2018-07-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome

Interventions

Therapy group:Adding Jiawei Qian-Yang Dan on the basis of comprehensive treatment of Western medicine
Control group:Western medicine comprehensive treatment + placebo

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1 Signed informed consent; 2 meets the diagnostic criteria of ARDS; 3 in line with TCM syndrome differentiation criteria; 4 patients aged older than 20 years and less than 70 years.

Exclusion criteria

Exclusion criteria: 1 pregnant or lactating women. 2 those who are allergic to the drugs used in the program. 3 patients with liver and kidney, hematopoietic system, metabolic endocrine system and other serious diseases leading to organ dysfunction.

Design outcomes

Primary

MeasureTime frame
;Extravascular lung water index;28-day mortality rate;Chest imaging;Mechanical ventilation time;ICU hospital stay;Oxygenation index;—

Countries

China

Contacts

Public ContactSong Zhang

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Zhangyuer2000@163.com+86 13880911582

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026